A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery
Status:
Completed
Trial end date:
2019-02-28
Target enrollment:
Participant gender:
Summary
Patients at least 40 years of age who are undergoing cataract surgery will be randomized to
receive treatment with one of two dose levels of dexamethasone ophthalmic suspension eye
drops to determine if the drops decrease inflammation inside the eye and are safe after
cataract surgery.